| 영문 | risk factor | 한글 | 위험인자 |
|---|---|---|---|
| 설명 | 국제방사선방호위원회(ICRP)가 1977년 권고에서 방사선방호의 목적으로 채택한 지수로, 단위선량(1 Sv)당 확률적 영향의 발생확률을 추정하여 나타낸 것이다. 생식선 선량에 대한 유전적영향의 발생률(4×10－3/Sv)이나 적색골수선량에 대한 백혈병 발생률(2×10－3/Sv)등 외에 뼈, 허파, 갑상샘, 젖샘, 기타 조직의 위험지수를 측정하여, 확률적 영향의 전신에 있어서 치사위험지수의 합계를 16.5×10－3/Sv로 하였다. 그후 ICRP는 1990년 권고에서 대상이 되는 조직과 장기를 추가하고, 수치 개정을 하면서 명칭도 각목적확률지수라고하였다. 이 권고에 의하면, 치사적 확률적 영향의 확률지수의 합계는, 일반인에 있어 60.0×10－3/Sv이다. |
||
| 영문 | physical examination | 한글 | 진찰, 신체검사 |
|---|---|---|---|
| 설명 | 1. 질병의 진단수단으로서 환자의 몸을 보는 진단. 만지는 진단, 두드리는 진단, 듣는 진단 등을 통하여 검사하는 것. 신체검사. 2. 건강상태를 알기 위하여 신체의 각 부분을 검사하는 일 또는 법원의 신체에 대한 증거 조사. 일반적으로는 흔히 소지품의 검사라는 뜻으로도 쓰인다. ② 학교보건법상 : 학생들의 체격검사-체질검사-체능검사를 말한다(2조). 학교의 장은 해마다 학생과 교직원의 신체검사를 해야 한다. 다만 교직원에 대한 신체검사는 ‘공무원 및 사립학교교직원 의료보험법’에 의한 건강진단으로 이에 갈음할 수 있다. 신체검사실시의 시기-방법-절차 등은 교육부령으로 정한다(7조). 학교의 장은 신체검사의 결과 전염병에 감염되었거나, 감염되었다는 혐의가 있거나 감염될 우려가 있는 자의 등교를 중지시킬 수 있다(8조). ② 형사소송법상 : 법원이 증거자료를 얻기 위하여 신체를 검증하는 것을 뜻한다. 법원은 사실발견에 필요하면 신체검사를 할 수 있고(140조), 감정인 및 수사기관도 신체검사를 할 수 있다(173-219조). 신체검사는 검사를 당하는 자의 성별-연령-건강상태 기타 사정을 고려하여, 그 사람의 건강과 명예를 해하지 아니하도록 주의하여야 한다. 여자의 신체 검사를 할 때에는 의사나 성년의 여자를 참여시켜야 한다(141조). 법원은 신체 검사를 하기 위하여, 피고인이 아닌 자를 법원 기타의 지정한 장소에 소환할 수 있다(142조). |
||
| NYHA | New York Heart Association Heart Disease에 대한 Functional Classification &nbs... |
|---|---|
| PE | Edinburgh Pharmacopoeia; pancreatic extract; paper electrophoresis; partial epilepsy; pelvic examina... |
| PT | pain threshold; parathormone; parathyroid; paroxysmal tachycardia; part time; patient; pericardial t... |
| AR | absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista... |
| CRI | Cardiac Risk Index; catheter-related infection; chronic renal insufficiency; chronic respiratory ins... |
| HACCP | Hazard Analysis Critical Control Point |
|---|---|
| HACCP | Hazard Analysis and Critical Control Point |
| HRR | Hazard Rate Ratio |
| HR | Hazard Ratio |
| RHR | Relative hazard rate |
| biological hazard potential | <radiobiology> Measure of the hazard posed by a given quantity of radioactive material in which the variation in biological effects of the various elements are accounted for. See: integrated biological hazard potential. (21 Mar 1998) |
|---|---|
| hazard | This is a general term for anything which has the ability to cause injury. The hazard associated with a potentially toxic substance is a function of its toxicity and the potential for exposure to the substance. The probability of exposure to the substance is a risk factor. (09 Oct 1997) |
| hazard rate | <statistics> Theoretical measure of the risk of occurrence of an event, e.g., death, new disease, at a point in time. (05 Mar 2000) |
| integrated biological hazard potential | <radiobiology> Total biological hazard potential of a collection of radioactive materials summed over their decay lifetimes. One measure of the integrated biological hazard potential is the amount of water one would need to use to dilute the materials to the point where the water would be safe to drink. (09 Oct 1997) |
| absolute risk | <statistics> The excess risk due to exposure to a specific hazard (disease, injury, etc.) (15 Jan 1998) |
| acceptable risk | <statistics> This relates to the potential for suffering disease or injury that will be tolerated by an individual, group, or society in exchange for the benefits of using a substance or process that will cause such disease or injury. Acceptability of risk depends on scientific data, social, economic, and political factors, and on the perceived benefits arising from a chemical or process that creates the risk in question. (15 Jan 1998) |
| attributable risk | The rate of a disease or other outcome in exposed individuals that can be attributed to the exposure. (05 Mar 2000) |
| cardiac risk | A term to describe overall risk of developing heart disease (blockage of the coronary arteries). Typical risk factors include: diabetes, high blood pressure, prior heart attack, high cholesterol, obesity, smoking and a family history for heart attacks in parents or siblings. (27 Sep 1997) |
| recurrence risk | In medical genetics, the recurrence risk is the chance that a genetic (inherited) disease present in the family will recur in that family and affect another person (or persons). It is the chance of lightning striking twice (or thrice, etc.). (12 Dec 1998) |
| glaucoma, risk factors | If you belong to a high-risk group for glaucoma, have your eyes examined through dilated pupils every 2 years by an eye care professional. High-risk groups include everyone with a family history of glaucoma, everyone over the age of 60 and any Black over the age of 40. (Among Blacks, studies show that glaucoma is: 5 times more likely to occur in Blacks than in Whites and about 4 times more likely to cause blindness in Blacks than in Whites). (12 Dec 1998) |
| relative risk | <epidemiology> The proportion of diseased people amongst those exposed to the relevant risk factor divided by the proportion of diseased people amongst those not exposed to the risk factor. This should be used in those cohort studies where those with and without disease are followed to observe which individuals become diseased. (05 Dec 1998) |
| risk | The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. (12 Dec 1998) |
| risk assessment | The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (12 Dec 1998) |
| risk benefit | An analysis of risk versus benefit is a complex assessment that must be made by a physician prior to the administration of a particular form of drug therapy. Since many medications may have side effects that can be harmful (during the course of treatment), the overall risk of a particular form of drug therapy must be weighed against the overall threat of the untreated disease process (or treatment with an altenative drug). (27 Sep 1997) |
| risk factor | <statistics> A clearly defined occurrence or characteristic that has been associated with the increased rate of a subsequently occurring disease. (14 Oct 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|